FORWARD GLOBAL for QUOIN PHARMACEUTICALS, INC.
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Medical/Disease Research/Clinical Labs MED
Lobbying for continued funding from the government for rare disease research and development, including through the Rare Pediatric Disease Designation and Priority Review Voucher Programs; advocating for greater awareness about the rare disease community for doctors via the Give Kids a Chance Act.
| Lobbyist | Covered position, as disclosed |
|---|---|
| LEAH CHARETTE | — |
| AVA COFIELL | — |
| NOE GARCIA | — |
Pharmacy PHA
Lobbying for continued funding from the government for rare disease research and development, including through the Rare Pediatric Disease Designation and Priority Review Voucher Programs; advocating for greater awareness about the rare disease community for doctors via the Give Kids a Chance Act.
| Lobbyist | Covered position, as disclosed |
|---|---|
| LEAH CHARETTE | — |
| AVA COFIELL | — |
| NOE GARCIA | — |
Health Issues HCR
Lobbying for continued funding from the government for rare disease research and development, including through the Rare Pediatric Disease Designation and Priority Review Voucher Programs; advocating for greater awareness about the rare disease community for doctors via the Give Kids a Chance Act.
| Lobbyist | Covered position, as disclosed |
|---|---|
| LEAH CHARETTE | — |
| AVA COFIELL | — |
| NOE GARCIA | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.